Topical tazarotene in treating patients with basal cell skin cancer and basal cell nevus syndrome

Journal of Drugs in Dermatology, Nov, 2007

Sponsors and Collaborators: University of California, San Francisco and National Cancer Institute (NCI). This phase II trial is studying topical tazarotene to see how well it works in treating patients with basal cell skin cancer and basal cell nevus syndrome.

Condition            Intervention             Phase

Neoplastic Syndrome  Drug: tazarotene         Phase II
Nonmelanomatous      Procedure: chemotherapy
  Skin Cancer

Study ID Numbers: CDR0000551655; UCSF-R01-CA-109584

ClinicalTrials.gov Identifier: NCT00489086